A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Clinical trial NCT07553429 · RECRUITING
Trial details
- NCT number
- NCT07553429
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-14
- Primary completion
- 2027-03-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.